The US men’s national soccer team’s World Cup performance is likely to have significant impact on broadcasters and high-flying investors. The World Cup has given backers who campaigned to hold it in ...

Buffer ETFs — funds that use leverage to protect investors from losses of upwards of 100% in some cases — might sound like the perfect product for more risk-averse clients. However, they also come ...

When it comes to investing, it’s the Wild West out there. Consumers, especially those who are less experienced, are constantly bombarded with so-called opportunities to make a bundle. We’re not ...

It’s not just real estate that’s all about location, location, location. Many clients worry they won’t have enough money saved to retire comfortably, assuming they’ll need more than $1 million by the ...

The spinoff has investors taking a fresh look at the sector, now split between old-school telecom and the AI-heavy giants ...

Contributions are now flowing after the Treasury Department launched its much-anticipated Trump account app this week. Any child under the age of 18 with a Social Security number can participate, and ...

The times they are tentatively, not with any certainty, maybe a-changin’. In a move borrowed from the founding members of the Justice League, a group of big US banks reportedly talked about banding ...

Gift tax returns? We don’t need no stinkin’ gift tax returns. The IRS released new guidance last week that largely (but not entirely) resolves concerns about Trump account contributions inadvertently ...

If it was really Mark Twain who said, “History doesn’t repeat itself, but it does rhyme,” he was right on the money. History class tells us those who got rich off the gold rush weren’t the miners. The ...

Shares in the membership-based retailer Costco fell 4.1% on Thursday after a June sales update failed to meet Wall Street’s lofty expectations. That continued a weeks-long slump, but it also means the ...

It was just another manic market day, at least for AstraZeneca. Shares of the British-Swedish biopharmaceutical company tumbled Thursday after it shared the surprising failure of its drug Wainua to ...